Inventor · disambiguated record
Andrew Hotson
Also filed as: HOTSON ANDREW
5 granted patents·7 pending applications·5 citations·filing 2016–2020
67Inventor score
Top patents by PatentIndex Score
12 records- 0183US10912776B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2016·Granted Feb 9, 2021·3 cites·12 claims
- 0276US11040040B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·2 cites·15 claims
- 0364US12023337B2Methods of treating cancerCORVUS PHARMACEUTICALS INC·Filed 2020·Granted Jul 2, 2024·0 cites·22 claims
- 0463US12174192B2Methods for detecting and treating cancers having adenosine pathway activationCORVUS PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·11 claims
- 0560US12116635B2Methods for detecting and treating cancers having adenosine pathway activationCORVUS PHARMACEUTICALS INC·Filed 2019·Granted Oct 15, 2024·0 cites·19 claims
- 0654US2017370934A1Methods and compositions for immunomodulationNODALITY INC·Filed 2017·Application pending·0 cites
- 0753US2017370933A1Methods and compositions for immunomodulationNODALITY INC·Filed 2017·Application pending·0 cites
- 0852US2024218073A1Immunomodulatory anti-cd73 antibodies and uses thereofCORVUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0951US2022242963A1B-cell activating cd73 antibodiesCORVUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1048US2020261462A1Combination therapy for cancer treatmentCORVUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1145US2021008206A1Adenosine pathway inhibitors for cancer treatmentCORVUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1226US2017199176A1T cell populations in diagnosis, prognosis, prediction, and monitoringNODALITY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Hotson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →